These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 9626471

  • 1. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
    Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H.
    Clin Cancer Res; 1998 Jun; 4(6):1517-20. PubMed ID: 9626471
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
    Hazelbag S, Kenter GG, Gorter A, Dreef EJ, Koopman LA, Violette SM, Weinreb PH, Fleuren GJ.
    J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
    [Abstract] [Full Text] [Related]

  • 3. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas.
    Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T.
    Cancer; 1996 Apr 15; 77(8):1501-9. PubMed ID: 8608535
    [Abstract] [Full Text] [Related]

  • 4. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
    Martens JE, Smedts F, ter Harmsel B, Helmerhorst TJ, Ramaekers FC.
    Anticancer Res; 1997 Apr 15; 17(6D):4305-9. PubMed ID: 9494525
    [Abstract] [Full Text] [Related]

  • 5. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.
    Kaku T, Sonoda K, Kamura T, Hirakawa T, Sakai K, Amada S, Ogawa S, Kobayashi H, Nakashima M, Watanabe T, Nakano H.
    Clin Cancer Res; 1999 Jun 15; 5(6):1449-53. PubMed ID: 10389931
    [Abstract] [Full Text] [Related]

  • 6. [Histopathologic and tumor-metric studies of stage Ia cervix cancer].
    Schumacher A, Schwarz R.
    Zentralbl Gynakol; 1989 Jun 15; 111(8):516-23. PubMed ID: 2741591
    [Abstract] [Full Text] [Related]

  • 7. Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells.
    Terasawa K, Furumoto H, Kamada M, Aono T.
    Cancer Res; 1996 May 01; 56(9):2229-32. PubMed ID: 8616877
    [Abstract] [Full Text] [Related]

  • 8. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 01; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 9. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
    Ievleva ES, Marshutina NV, Ageenko AN, Khmel'nitskaia NG.
    Biull Eksp Biol Med; 1992 Mar 01; 113(3):304-6. PubMed ID: 1421235
    [Abstract] [Full Text] [Related]

  • 10. Expression of HuR is associated with increased cyclooxygenase-2 expression in uterine cervical carcinoma.
    Lim SJ, Kim HJ, Kim JY, Park K, Lee CM.
    Int J Gynecol Pathol; 2007 Jul 01; 26(3):229-34. PubMed ID: 17581403
    [Abstract] [Full Text] [Related]

  • 11. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
    Dellas A, Schultheiss E, Leivas MR, Moch H, Torhorst J.
    Anticancer Res; 1998 Jul 01; 18(6A):3991-8. PubMed ID: 9891436
    [Abstract] [Full Text] [Related]

  • 12. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
    Umezaki K, Sanezumi M, Okada H, Okamura A, Tsubra A, Kanazaki H.
    Gynecol Oncol; 1997 Sep 01; 66(3):393-8. PubMed ID: 9299251
    [Abstract] [Full Text] [Related]

  • 13. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix.
    Rodríguez-Sastre MA, González-Maya L, Delgado R, Lizano M, Tsubaki G, Mohar A, García-Carrancá A.
    Gynecol Oncol; 2005 May 01; 97(2):330-6. PubMed ID: 15863126
    [Abstract] [Full Text] [Related]

  • 14. Cancer cells located deep in invasive cancer tissue of the uterine cervix.
    Kishi Y, Doi T, Inui S, Yasuda M, Fujita H, Furuta N, Adachi H.
    Tokushima J Exp Med; 1977 Dec 01; 24(3-4):89-93. PubMed ID: 613493
    [No Abstract] [Full Text] [Related]

  • 15. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma.
    Rintala M, Inki P, Klemi P, Jalkanen M, Grénman S.
    Gynecol Oncol; 1999 Dec 01; 75(3):372-8. PubMed ID: 10600292
    [Abstract] [Full Text] [Related]

  • 16. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
    Murakami A, Nakagawa T, Fukushima C, Torii M, Sueoka K, Nawata S, Takeda O, Ishikawa H, Sugino N.
    Oncol Rep; 2008 Jan 01; 19(1):99-104. PubMed ID: 18097581
    [Abstract] [Full Text] [Related]

  • 17. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A, Imamura Y, Noriki S, Fukuda M.
    Eur J Histochem; 2000 Jan 01; 44(2):143-56. PubMed ID: 10968362
    [Abstract] [Full Text] [Related]

  • 18. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
    Nagai N, Oshita T, Murakami J, Ohama K.
    Oncol Rep; 1999 Jan 01; 6(2):325-8. PubMed ID: 10022998
    [Abstract] [Full Text] [Related]

  • 19. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
    Yu W, Liu J, Xiong X, Ai Y, Wang H.
    Pathol Res Pract; 2009 Jan 01; 205(10):709-15. PubMed ID: 19541433
    [Abstract] [Full Text] [Related]

  • 20. [Loss of beta 2 microglobulin from the surface of "dysplastic" and malignant epithelial cells of the uterine cervix].
    Tseleni-Balafouta S, Balafoutas AC, Paraskevakou H.
    Zentralbl Gynakol; 1989 Jan 01; 111(11):744-8. PubMed ID: 2675495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.